Dexcom
Continuous Glucose Monitoring.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | $1.0b | Post IPO Convertible |
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 27 % | 19 % | 24 % | 11 % | 14 % | 15 % | 14 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 11 % | 14 % | 25 % | 23 % | 30 % | 32 % | 34 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 6 % | 12 % | 15 % | 14 % | 17 % | 19 % | 21 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 25 % | 17 % | 14 % | 14 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Dexcom, Inc. specializes in developing and marketing continuous glucose monitoring (CGM) systems for diabetes management. The company's core product, the Dexcom G6 CGM System, provides real-time glucose readings to patients, allowing them to manage their condition more effectively. Dexcom serves a diverse client base, including individuals with diabetes, healthcare providers, and caregivers. Operating in the global healthcare market, Dexcom's business model revolves around the sale of CGM devices and related software applications, such as Dexcom CLARITY, which offers data analytics and insights. Revenue is primarily generated through the sale of these devices and subscription-based services for data management. Dexcom's innovative technology aims to improve the quality of life for diabetes patients by offering accurate, easy-to-use glucose monitoring solutions.
Keywords: continuous glucose monitoring, diabetes management, real-time data, Dexcom G6, healthcare, glucose readings, CGM devices, data analytics, subscription services, patient care.
Tech stack
Investments by Dexcom
Edit
